BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yu X, Sun Q, Zhang Y, Zou L, Zhao Y. TGF-β/Smad Signaling Pathway in Tubulointerstitial Fibrosis. Front Pharmacol 2022;13:860588. [DOI: 10.3389/fphar.2022.860588] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Xu Y, Chen J, Wang H, Lu Y. Research and application of herbal medicine in the treatment of chronic kidney disease since the 21st century: A visualized bibliometric analysis. Front Pharmacol 2022;13:971113. [DOI: 10.3389/fphar.2022.971113] [Reference Citation Analysis]
2 Miao H, Zhang Y, Yu X, Zou L, Zhao Y. Membranous nephropathy: Systems biology-based novel mechanism and traditional Chinese medicine therapy. Front Pharmacol 2022;13:969930. [DOI: 10.3389/fphar.2022.969930] [Reference Citation Analysis]
3 Mo C, Zhao J, Liang J, Wang H, Chen Y, Huang G. Exosomes: A novel insight into traditional Chinese medicine. Front Pharmacol 2022;13:844782. [DOI: 10.3389/fphar.2022.844782] [Reference Citation Analysis]
4 Sánchez-jaramillo EA, Gasca-lozano LE, Vera-cruz JM, Hernández-ortega LD, Salazar-montes AM. Automated Computer-Assisted Image Analysis for the Fast Quantification of Kidney Fibrosis. Biology 2022;11:1227. [DOI: 10.3390/biology11081227] [Reference Citation Analysis]
5 Wang Y, Liu H, Ren L, Suo P, Zou L, Zhang Y, Yu X, Zhao Y. Shenkang injection improves chronic kidney disease by inhibiting multiple renin-angiotensin system genes by blocking the Wnt/β-catenin signalling pathway. Front Pharmacol 2022;13:964370. [DOI: 10.3389/fphar.2022.964370] [Reference Citation Analysis]
6 Wang YN, Zhang ZH, Liu HJ, Guo ZY, Zou L, Zhang YM, Zhao YY. Integrative phosphatidylcholine metabolism through phospholipase A2 in rats with chronic kidney disease. Acta Pharmacol Sin 2022. [PMID: 35922553 DOI: 10.1038/s41401-022-00947-x] [Reference Citation Analysis]
7 Zhao Y. Recent advances of gut microbiota in chronic kidney disease patients. Exploration of Medicine. [DOI: 10.37349/emed.2022.00090] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Wang Y, Feng H, Nie X, Zhang Y, Zou L, Li X, Yu X, Zhao Y. Recent Advances in Clinical Diagnosis and Pharmacotherapy Options of Membranous Nephropathy. Front Pharmacol 2022;13:907108. [DOI: 10.3389/fphar.2022.907108] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
9 Cao G, Miao H, Wang YN, Chen DQ, Wu XQ, Chen L, Guo Y, Zou L, Vaziri ND, Li P, Zhao YY. Intrarenal 1-methoxypyrene, an aryl hydrocarbon receptor agonist, mediates progressive tubulointerstitial fibrosis in mice. Acta Pharmacol Sin 2022. [PMID: 35577910 DOI: 10.1038/s41401-022-00914-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
10 Tan Y, Wang Y, Feng H, Guo Z, Li X, Nie X, Zhao Y. Host/microbiota interactions-derived tryptophan metabolites modulate oxidative stress and inflammation via aryl hydrocarbon receptor signaling. Free Radical Biology and Medicine 2022. [DOI: 10.1016/j.freeradbiomed.2022.03.025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]